Monday, March 30th, 2026

DDA directs withdrawal of substandard drugs from the market



KATHMANDU: The Department of Drug Administration has given instructions to withdraw the drug Zincomin-DT in the market.

After the medicine was found to be of low quality, the department instructed Nova Genetica Pvt Ltd Khanikhola-7, Naubise, Dhading to recall the medicine.

Issuing a notice on Sunday, DDA directed to recall the medicine and ensured that Zincomin will be returned, not sold and distributed as the medicine did not comply with respect to disintegration test carried out after the market monitoring.

The Department also instructed the medical practitioners not to recommend Nova’s Zincomin.

Publish Date : 28 August 2022 15:28 PM

Rescue of street-dependent people begins in Lumbini Province

LUMBINI: Manav Sewa Ashram has launched the 2082 rescue campaign

Reminiscing last week: Power shift sparks storm

KATHMANDU: The past week marks one of the most consequential

Economic Digest: Nepal’s Business News in a Snap

KATHMANDU: Economic Digest offers a concise yet comprehensive overview of

Trump signals possible move on Iran’s Kharg Island as oil prices surge

WASHINGTON DC: Former US President Donald Trump has said he

Cloudy skies, scattered showers expected today

KATHMANDU: Westerly winds, along with local wind systems, are currently